• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北卡罗来纳州 SARS-CoV-2 德尔塔波的时空特征。

Spatiotemporal characteristics of the SARS-CoV-2 Delta wave in North Carolina.

机构信息

Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Spat Spatiotemporal Epidemiol. 2023 Jun;45:100566. doi: 10.1016/j.sste.2023.100566. Epub 2023 Jan 13.

DOI:10.1016/j.sste.2023.100566
PMID:37301588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9838034/
Abstract

We constructed county-level models to examine properties of the SARS-CoV-2 B.1.617.2 (Delta) variant wave of infections in North Carolina and assessed immunity levels (via prior infection, via vaccination, and overall) prior to the Delta wave. To understand how prior immunity shaped Delta wave outcomes, we assessed relationships among these characteristics. Peak weekly infection rate and total percent of the population infected during the Delta wave were negatively correlated with the proportion of people with vaccine-derived immunity prior to the Delta Wave, signaling that places with higher vaccine uptake had better outcomes. We observed a positive correlation between immunity via infection prior to Delta and percent of the population infected during the Delta wave, meaning that counties with poor pre-Delta outcomes also had poor Delta wave outcomes. Our findings illustrate geographic variation in outcomes during the Delta wave in North Carolina, highlighting regional differences in population characteristics and infection dynamics.

摘要

我们构建了县级模型,以研究北卡罗来纳州 SARS-CoV-2 B.1.617.2(Delta)变异株感染波的特征,并评估了 Delta 波之前的免疫水平(通过既往感染、通过疫苗接种和总体水平)。为了了解既往免疫如何影响 Delta 波的结果,我们评估了这些特征之间的关系。Delta 波期间每周感染率峰值和感染总人数百分比与 Delta 波之前具有疫苗衍生免疫力的人群比例呈负相关,表明疫苗接种率较高的地区结果较好。我们观察到 Delta 波之前感染获得的免疫力与 Delta 波期间感染人数百分比之间呈正相关,这意味着 Delta 波之前结果较差的县,Delta 波的结果也较差。我们的研究结果说明了北卡罗来纳州 Delta 波期间结果的地理差异,突出了人口特征和感染动态的地区差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/171b62261bc5/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/8599c7604125/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/701e8f7df32d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/705a9bd8ae0b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/dfb8a5f1cece/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/c1104e307c3a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/171b62261bc5/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/8599c7604125/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/701e8f7df32d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/705a9bd8ae0b/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/dfb8a5f1cece/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/c1104e307c3a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72dc/9838034/171b62261bc5/gr6_lrg.jpg

相似文献

1
Spatiotemporal characteristics of the SARS-CoV-2 Delta wave in North Carolina.北卡罗来纳州 SARS-CoV-2 德尔塔波的时空特征。
Spat Spatiotemporal Epidemiol. 2023 Jun;45:100566. doi: 10.1016/j.sste.2023.100566. Epub 2023 Jan 13.
2
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
3
COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA.美国北卡罗来纳州 COVID-19 社区研究合作组织中,不同变异株流行时期的 COVID-19 症状。
Emerg Infect Dis. 2023 Jan;29(1):207-211. doi: 10.3201/eid2901.221111.
4
SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.埃塞俄比亚霍瓦萨地区学龄儿童中的 SARS-CoV-2 感染和 mRNA 疫苗诱导的体液免疫。
Front Immunol. 2023 Jun 15;14:1163688. doi: 10.3389/fimmu.2023.1163688. eCollection 2023.
5
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
6
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination.印度的 COVID-19 大流行动态、SARS-CoV-2 德尔塔变异株及其对疫苗接种的影响。
J R Soc Interface. 2022 Jun;19(191):20210900. doi: 10.1098/rsif.2021.0900. Epub 2022 Jun 6.
7
Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.接种疫苗状态下感染 SARS-CoV-2 德尔塔变异株后儿童多系统炎症综合征的发生率和临床表型:一项丹麦全国前瞻性队列研究。
Lancet Child Adolesc Health. 2022 Jul;6(7):459-465. doi: 10.1016/S2352-4642(22)00100-6. Epub 2022 May 6.
8
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
9
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.英国未接种和接种疫苗人群中 SARS-CoV-2 德尔塔(B.1.617.2)变异株的社区传播和病毒载量动力学:一项前瞻性、纵向、队列研究。
Lancet Infect Dis. 2022 Feb;22(2):183-195. doi: 10.1016/S1473-3099(21)00648-4. Epub 2021 Oct 29.
10
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.

引用本文的文献

1
Integrating data at multiple spatial scales to estimate the local burden of the opioid syndemic.整合多个空间尺度的数据以估计阿片类药物共病的局部负担。
Spat Spatiotemporal Epidemiol. 2025 Jun;53:100720. doi: 10.1016/j.sste.2025.100720. Epub 2025 Apr 22.

本文引用的文献

1
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022.COVID-19 疫苗接种服务可及性及 5-11 岁儿童疫苗接种覆盖率 - 美国,2021 年 11 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 11;71(10):378-383. doi: 10.15585/mmwr.mm7110a4.
2
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-January 31, 2022.城乡地区 COVID-19 疫苗接种率的差异-美国,2020 年 12 月 14 日-2022 年 1 月 31 日。
MMWR Morb Mortal Wkly Rep. 2022 Mar 4;71(9):335-340. doi: 10.15585/mmwr.mm7109a2.
3
COVID-19 Incidence and hospitalization during the delta surge were inversely related to vaccination coverage among the most populous U.S. Counties.
在德尔塔毒株激增期间,美国人口最多的几个县的新冠病毒感染率和住院率与疫苗接种覆盖率呈负相关。
Health Policy Technol. 2022 Jun;11(2):100583. doi: 10.1016/j.hlpt.2021.100583. Epub 2021 Nov 30.
4
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.促进 COVID-19 疫苗接种:美国 Lancet 委员会关于疫苗拒绝、接受和需求的建议。
Lancet. 2021 Dec 11;398(10317):2186-2192. doi: 10.1016/S0140-6736(21)02507-1. Epub 2021 Nov 15.
5
Analysis of the Delta Variant B.1.617.2 COVID-19.新冠病毒Delta变异株B.1.617.2的分析
Clin Pract. 2021 Oct 21;11(4):778-784. doi: 10.3390/clinpract11040093.
6
Delta coronavirus variant: scientists brace for impact.德尔塔冠状病毒变种:科学家们严阵以待。
Nature. 2021 Jul;595(7865):17-18. doi: 10.1038/d41586-021-01696-3.
7
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.城乡地区 COVID-19 疫苗接种覆盖率差距 - 美国,2020 年 12 月 14 日-2021 年 4 月 10 日。
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):759-764. doi: 10.15585/mmwr.mm7020e3.
8
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.辉瑞-生物科技和莫德纳 COVID-19 疫苗在医护人员中的疫苗有效性的临时估计 - 2021 年 1 月至 3 月,美国 33 个地点。
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):753-758. doi: 10.15585/mmwr.mm7020e2.
9
The Geography of the Covid-19 Pandemic: A Data-Driven Approach to Exploring Geographical Driving Forces.新冠疫情的地理分布:一种探索地理驱动因素的基于数据的方法。
Int J Environ Res Public Health. 2021 Mar 10;18(6):2803. doi: 10.3390/ijerph18062803.
10
County-Level COVID-19 Vaccination Coverage and Social Vulnerability - United States, December 14, 2020-March 1, 2021.县级 COVID-19 疫苗接种覆盖率与社会脆弱性-美国,2020 年 12 月 14 日-2021 年 3 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):431-436. doi: 10.15585/mmwr.mm7012e1.